he CMO Gallus BioPharmaceutical has acquired the biologics CMO Laureate Biopharmaceutical Services.

The first part of CPhI’s Annual Expert Industry Report examines ADCs, single-use technology, and regulatory failure.

Ireland?s life-sciences sector has grown significantly since the 1960s. To gain insights into the competitive edge that Ireland offers to the pharmaceutical industry, Pharmaceutical Technology Europe spoke with Barry Heavey from IDA Ireland, which is a government agency responsible for attracting pharmaceutical and biotech companies to Ireland.

The pharmaceutical industry grows despite conflict in the Middle East.

GlaxoSmithKline?s sale of its thrombosis brands is part of a focus on its late-stage pipeline.

Fujifilm Diosynth Biotechnologies? new mammalian cell-culture facility uses primarily single-use technologies.

USP seeks input from stakeholders on new and revised standards to mitigate extractables and leachables in plastic packaging systems.

Foreign companies zero in on Myanmar with the hope of securing a foothold in its pharmaceutical market.

Cambridge Major Laboratories and AAIPharma Services plan to merge to form a global supplier of integrated CMC services.

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Contract service providers position in China as biopharmaceutical and pharmaceutical companies align their strategies in emerging markets for growth.

A look at the happenings at this year's installment of CPhI Worldwide.

Contract manufacturers of both APIs and finished products expand manufacturing capacity and services for high-potency manufacturing.

A roundup of expansion activity of manufacturing capacity and service offerings from fine-chemical producers and contract API manufacturers.

Merck announced plans to reduce its workforce by 8,500 and move its headquarters in order to sharpen its commercial and R&D focus.

DSM Pharmaceutical Products appoints a new CEO and President.

Researchers from the University of Bradford, UK, have developed a solvent-free, continuous method to manufacture the more soluble and bioavailable form of artemisinin. The metastable form produced using high-temperature extrusion has been shown to have greater stability and longer shelf-life.

FDA publishes guidance on ANDA submissions.

EMA revises HIV treatment guideline.

The collaboration with Pfizer aims to develop next-generation, continuous manufacturing for solid-dosage pharmaceuticals.

Ablynx and AbbVie sign license agreement for Anti-IL-6R Nanobody, ALX-0061 to treat inflammatory diseases.

Cedarburg Hauser Pharmaceuticals has upgraded its API plant in Wisconsin.

Catalent Applied Drug Delivery Institute appoints Claus-Michael Lehr to advisory board.

West Pharmaceutical Services opens its second manufacturing plant in China to expand presence in Asian markets.

Perrigo appoints Keith Webber as head of regulatory review.

J&J's Janssen and PATH partner to improve drug formulation that could help prevent HIV infection.

ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.

Coldstream Laboratories partners with the National Cancer Institute for developing parental dosage forms for cancer drugs.